MEPI-1

Studying Disease Reinfection Rates, Vaccine Efficacy and the Timing of Vaccine Rollout in the context of Infectious Diseases

SMB2025 SMB2025 Follow
Share this

ElizabethAmona

Virginia Commonwealth University
"Studying Disease Reinfection Rates, Vaccine Efficacy and the Timing of Vaccine Rollout in the context of Infectious Diseases"
The global landscape has undergone distinct waves of COVID-19 infections, compounded by the emergence of variants, thereby introducing additional complexities to the ongoing pandemic. This research uniquely explores the varied efficacy of existing vaccines and the pivotal role of vaccination timing in the context of COVID-19. Departing from conventional modeling, we introduce two models that account for the impact of vaccines on infections, reinfections, and deaths. We estimate model parameters under the Bayesian framework, specifically utilizing the Metropolis-Hastings Sampler. The study conducts data-driven scenario analyses for the State of Qatar, quantifying the potential duration during which the healthcare system could have been overwhelmed by an influx of new COVID-19 cases surpassing available hospital beds. Additionally, the research explores similarities in predictive probability distributions of cumulative infections, reinfections, and deaths, employing the Hellinger distance metric. Comparative analysis, utilizing the Bayes factor, underscores the plausibility of a model assuming a different susceptibility rate to reinfection, as opposed to assuming the same susceptibility rate for both infections and reinfections. Results highlight the adverse outcomes associated with delayed vaccination, emphasizing the efficacy of early vaccination in reducing infections, reinfections, and deaths. Our research advocates prioritizing early vaccination as a key strategy in effectively combating future pandemics. This study contributes vital insights for evidence-based public health interventions, providing clarity on vaccination strategies and reinforcing preparedness for challenges posed by infectious diseases.
Additional authors:



SMB2025
#SMB2025 Follow
Annual Meeting for the Society for Mathematical Biology, 2025.